Effect of three cueing devices (visual, auditory, and vibration) for people with Parkinson’s disease with freezing of gait difficulties

计划入组 25 人

Randomized control clinical trial to assess the effect of meditation on selected clinical outcomes in patients with Parkinson’s disease and epilepsy.

sing N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s Disease

计划入组 44 人

neuroprotectants (Parkinson’s disease)

Parkinson’s Disease(Nitrase)

drug candidate (Parkinson’s disease)

Annexon

United States

Minerva Neurosciences

United States

HARVEST TRAVEL & LEISURE INCOME ETF UNIT CL A

United States

First Participants Randomized in AskBio Phase II Gene Therapy Trial for Parkinson’s Disease

AskBio's AB-1005 Gene Therapy for Parkinson’s Disease Meets Primary Endpoint in Phase Ib Trial

FDA Approves Crexont for Parkinson's Disease Treatment